News
The Latest Industry News
What are the GI side effects of GLP-1RA Medications, like Ozempic?
Posted on February 9, 2024In treating T2D diabetes patients, our Texas Diabetes & Endocrinology board-certified experts may recommend medication to help lower blood sugars in addition to lifestyle changes. Some injectable forms of medical therapy, known as GLP-1RA medications, have been trending in the news lately due to their role in weight-loss management. These drugs go by popular brand names such as Ozempic, Mounjaro, and Trulicity. While […]
Read More
Texas Diabetes First to Offer New Treatment to Delay Stages of T1D
Posted on January 24, 2024At Texas Diabetes & Endocrinology, we take pride in offering the most innovative treatments and top clinical trials for conditions affecting the endocrine system, like diabetes. Recently one of our patients, Liberty, became the first person in Central Texas to try a new drug, TZIELD, to delay the onset of stage 3 type 1 diabetes (T1D). TZIELD is an infusion-based treatment that […]
Read More
Congratulations to our 2024 Top Doctors
Posted on January 19, 2024We welcomed the new year celebrating board certified endocrinologists Valerie Espinosa, MD and Lindsay Harrison, MD for being recognized on the 2024 Top Doctors list in Austin Monthly magazine. Dr. Espinosa joined Texas Diabetes and Endocrinology in 2005. She is board certified in endocrinology and metabolism and active in clinical research concerning diabetes, obesity and thyroid disease. […]
Read More
Heart Disease and the T2D Connection
Posted on January 8, 2024People with diabetes are twice as likely to have heart disease or suffer a stroke than non-diabetics. In fact, the American Heart Association recently issued its Heart Disease and Stroke Statistics for 2023 which found that one in three adults in the U.S. have three or more risk factors that contribute to cardiovascular disease, metabolic disorders, and/or kidney disease. This […]
Read MorePOSTS BY TOPIC
